Research Papers

25 of 3340 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Antiviral Potential of Azathioprine and Its Derivative 6- Mercaptopurine: A Narrative Literature Review.
Rios-Usuga C; Martinez-Gutierrez M; Ruiz-Saenz J.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Machine Learning Application for Medicinal Chemistry: Colchicine Case, New Structures, and Anticancer Activity Predicti…
Nowak D; Huczyński A; Bachorz RA; Hoffmann M.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
5/6 Transparent
Data Code Funding Declared
Chitosan-Based Polymeric Nanoparticles as an Efficient Gene Delivery System to Cross Blood Brain Barrier: In Vitro and …
Khan IN; Navaid S; Waqar W; Hussein D; Ullah N; Khan MUA; Hussain Z; Javed A.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Synthesis, Characterization, and Toxicity Assessment of Zinc Oxide-Doped Manganese Oxide Nanoparticles in a Macrophage …
Alsaleh NB; Aljarbou AM; Assal ME; Assiri MA; Almutairi MM; As Sobeai HM; Alshamrani AA; Almudimeegh S; Hatshan MR; Adil SF.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Re…
Alvarez-Herrera S; Rosel Vales M; Pérez-Sánchez G; Becerril-Villanueva E; Flores-Medina Y; Maldonado-García JL; Saracco-Alvarez R; Escamilla R; Pavón L.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Synergistic Anti-Inflammatory Activity of Apolipoprotein A-I and CIGB-258 in Reconstituted High-Density Lipoproteins (r…
Cho KH; Kim JE; Kang DJ; Dominguez-Horta MDC; Martinez-Donato G.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
[<sup>18</sup>F]Fluspidine-A PET Tracer for Imaging of σ<sub>1</sub> Receptors in the Central Nervous System.
Ludwig FA; Laurini E; Schmidt J; Pricl S; Deuther-Conrad W; Wünsch B.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Bioavailability of Oral Curcumin in Systematic Reviews: A Methodological Study.
Bučević Popović V; Karahmet Farhat E; Banjari I; Jeličić Kadić A; Puljak L.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Fluorescent Graphitic Carbon Nitride (g-C<sub>3</sub>N<sub>4</sub>)-Embedded Hyaluronic Acid Microgel Composites for Bi…
Suner SS; Sahiner M; Demirci S; Umut E; Sahiner N.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics.
Cha Y; Kagalwala MN; Ross J.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Functional Analysis of TRPA1, TRPM3, and TRPV1 Channels in Human Dermal Arteries and Their Role in Vascular Modulation.
Rivera-Mancilla E; Al-Hassany L; Marynissen H; Bamps D; Garrelds IM; Cornette J; Danser AHJ; Villalón CM; de Hoon JN; MaassenVanDenBrink A.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Antibacterial and Anti-Biofilm Efficacy of Endolysin LysAB1245 against a Panel of Important Pathogens.
Soontarach R; Srimanote P; Voravuthikunchai SP; Chusri S.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Xiao Cheng Qi Decoction, an Ancient Chinese Herbal Mixture, Relieves Loperamide-Induced Slow-Transit Constipation in Mi…
Tuohongerbieke A; Wang H; Wu J; Wang Z; Dong T; Huang Y; Zhu D; Sun D; Tsim KWK.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy.
Dal Bello S; Lorenzut S; Saccomano E; Tereshko Y; Gigli GL; Pucillo CE; Valente M.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice.
Zhang C; Su H; Waight E; Poluektova LY; Gorantla S; Gendelman HE; Dash PK.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice.
Bernard A; Mroué M; Bourthoumieu S; Boyce M; Richard L; Sturtz F; Demiot C; Danigo A.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Toxicity and Toxicokinetics of a Four-Week Repeated Gavage of Levamisole in Male Beagle Dogs: A Good Laboratory Practic…
Zhang J; Wang J; Chen L; Yu X; Zhang S; Yu Y.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Con…
Kokoszka A.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Natural Products for Cancer Prevention and Interception: Preclinical and Clinical Studies and Funding Opportunities.
Sauter ER; Mohammed A.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Influence of Long-Term Anti-Seizure Medications on Redox Parameters in Human Blood.
Jakovljević D; Nikolić M; Jovanović V; Vidonja Uzelac T; Nikolić-Kokić A; Novaković E; Miljević Č; Milovanović M; Blagojević D.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Acute Kidney Injury Caused by Rhabdomyolysis Is Ameliorated by Serum Albumin-Based Supersulfide Donors through Antioxid…
Ikeda-Imafuku M; Fukuta T; Tuan Giam Chuang V; Sawa T; Maruyama T; Otagiri M; Ishida T; Ishima Y.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Tocilizumab Exerts Anti-Tumor Effects on Colorectal Carcinoma Cell Xenografts Corresponding to Expression Levels of Int…
Chung YC; Chen SJ; Huang CC; Liu WC; Lai MT; Kao TY; Yang WS; Yang CH; Hsu CP; Chang JF.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium.
Li Y; Zhang M; Zhang S; Yang G.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Comprehensive Review on Deep Eutectic Solvents and Its Use to Extract Bioactive Compounds of Pharmaceutical Interest.
Ferreira C; Sarraguça M.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pharmacology of <i>Veratrum californicum</i> Alkaloids as Hedgehog Pathway Antagonists.
Dirks ML; McDougal OM.
Pharmaceuticals (Basel) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared